Sign in
CompletedNo phase

Real-World Study of Helicobacter Pylori Eradication Success and Its Determinants

Key facts

Who runs it
Run-hua Li
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
3,000 people enrolled
Started
1 May 2024
Ended
31 May 2025
Type of study
Observational
Treatments tested
  • No Study-Assigned Intervention
Record updated
29 January 2026

Who can take part

Age
14 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Age ≥ 14 years
  • Patients who underwent Helicobacter pylori (H. pylori) testing and/or eradication treatment at Shenzhen Hospital of Southern Medical University between 2016 and 2023
  • Diagnosis of H. pylori infection based on the Sixth National Consensus Report on the Management of Helicobacter pylori Infection (Non-Eradication Section) or clinically accepted testing methods

Who cannot take part

  • Children younger than 14 years old
  • Pregnant or breastfeeding women
  • Patients deemed unsuitable for participation by the investigator based on clinical judgment

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to evaluate the real-world effectiveness of different treatment regimens used to eradicate Helicobacter pylori (H. pylori) infection in routine clinical practice. H. pylori is a common bacterial infection that can lead to chronic gastritis, peptic ulcers, and gastric cancer. Treatment success varies widely in real-world settings due to factors such as antibiotic resistance, patient characteristics, and treatment adherence.

Read full original descriptionShow less

This retrospective observational study will review medical records of patients who underwent H. pylori testing and/or eradication treatment at Shenzhen Hospital of Southern Medical University between 2016 and 2023. No additional tests, visits, or interventions will be performed beyond standard clinical care. The study will collect information on demographics, comorbidities, treatment regimens, test results, and eradication outcomes.

The primary goal is to determine the real-world eradication success rate of commonly used treatment regimens. A secondary goal is to identify factors that may influence treatment effectiveness. Findings from this study may help clinicians choose more effective treatment strategies and improve patient outcomes in everyday clinical practice.

The group in the trial

  • Patients With Helicobacter pylori Infection

    Participants who underwent H. pylori testing and/or eradication treatment at Shenzhen Hospital of Southern Medical University between 2016 and 2023. This cohort includes patients receiving different eradication regimens as part of routine clinical care. No study-assigned interventions are provided.

    Treatment: No Study-Assigned Intervention

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Study on the Real-World Eradication Success Rate of Helicobacter Pylori Infection and Its Influencing Factors
Record updated
29 January 2026